Literature DB >> 26542588

Limited Parathyroidectomy in Multiple Endocrine Neoplasia Type 1-Associated Primary Hyperparathyroidism: A Setup for Failure.

Naris Nilubol1, Lee S Weinstein2, William F Simonds2, Robert T Jensen3, Stephen J Marx2, Electron Kebebew4.   

Abstract

BACKGROUND: Recently, some surgeons have suggested that minimally invasive parathyroidectomy guided by preoperative localizing studies of patients with multiple endocrine neoplasia type 1 (MEN1)-associated primary hyperparathyroidism (pHPT) provides an acceptable outcome while minimizing the risk of hypoparathyroidism. This study aimed to evaluate the outcome for MEN1 patients who underwent limited parathyroidectomy compared with subtotal parathyroidectomy.
METHODS: The authors performed a retrospective analysis of 99 patients with MEN1-associated pHPT who underwent at least one parathyroid operation at their institution. Preoperative imaging studies, intraoperative findings, and clinical outcomes for patients were compared.
RESULTS: A total of 99 patients underwent 146 operations. Persistent pHPT was significantly higher in patients whose initial operations involved removal of 1 or 2 glands (69 %) or 2.5 to 3 glands (20 %) compared with those who had 3.5 or more glands removed (6 %) (P < 0.01). Persistent pHPT occurred in 5 % of all operations that cumulatively removed 3.5 or more parathyroid glands compared with 40 % of operations that removed 3 or fewer glands (P < 0.01). The single largest parathyroid gland was correctly identified preoperatively in 69 % (22/32) of the patients. However, preoperative localizing studies missed enlarged contralateral parathyroid glands in 86 % (19/22) of these patients. Preoperative localizing studies missed the largest contralateral parathyroid gland in 16 % (5/32) of the patients.
CONCLUSIONS: Limited parathyroidectomy in MEN1 is associated with a high failure rate and should not be performed. Preoperative identification of a single enlarged parathyroid gland in MEN1 is not reliable enough to justify unilateral neck exploration because additional enlarged contralateral parathyroid glands are frequently missed.

Entities:  

Mesh:

Year:  2015        PMID: 26542588     DOI: 10.1245/s10434-015-4865-9

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  13 in total

1.  Impact of "Tailored" Parathyroidectomy for Treatment of Primary Hyperparathyroidism in Patients with Multiple Endocrine Neoplasia Type 1.

Authors:  Kiyomi Horiuchi; Momoko Sakurai; Kento Haniu; Erin Nagai; Hiroki Tokumitsu; Yusaku Yoshida; Yoko Omi; Akiko Sakamoto; Takahiro Okamoto
Journal:  World J Surg       Date:  2018-06       Impact factor: 3.352

2.  In Response to the Article Entitled "Unilateral Clearance for Primary Hyperparathyroidism in Selected Patients with Multiple Endocrine Neoplasia Type 1".

Authors:  Raouef Ahmed Bichoo; Anjali Mishra
Journal:  World J Surg       Date:  2017-01       Impact factor: 3.352

3.  Management of primary and renal hyperparathyroidism: guidelines from the German Association of Endocrine Surgeons (CAEK).

Authors:  T Weber; C Dotzenrath; H Dralle; B Niederle; P Riss; K Holzer; J Kußmann; A Trupka; T Negele; R Kaderli; E Karakas; F Weber; N Rayes; A Zielke; M Hermann; C Wicke; R Ladurner; C Vorländer; J Waldmann; O Heizmann; S Wächter; S Schopf; W Timmermann; D K Bartsch; R Schmidmaier; M Luster; K W Schmid; M Ketteler; C Dierks; P Schabram; T Steinmüller; K Lorenz
Journal:  Langenbecks Arch Surg       Date:  2021-04-21       Impact factor: 3.445

4.  Familial isolated primary hyperparathyroidism associated with germline GCM2 mutations is more aggressive and has a lesser rate of biochemical cure.

Authors:  Mustapha El Lakis; Pavel Nockel; Bin Guan; Sunita Agarwal; James Welch; William F Simonds; Stephen Marx; Yulong Li; Naris Nilubol; Dhaval Patel; Lily Yang; Roxanne Merkel; Electron Kebebew
Journal:  Surgery       Date:  2017-11-03       Impact factor: 3.982

5.  Unilateral Clearance for Primary Hyperparathyroidism in Selected Patients with Multiple Endocrine Neoplasia Type 1.

Authors:  Wouter P Kluijfhout; Toni Beninato; Frederick Thurston Drake; Menno R Vriens; Jessica Gosnell; Wen T Shen; Insoo Suh; Chienying Liu; Quan-Yang Duh
Journal:  World J Surg       Date:  2016-12       Impact factor: 3.352

6.  Questions and Controversies About Parathyroid Pathophysiology in Children With Multiple Endocrine Neoplasia Type 1.

Authors:  Stephen J Marx; Delmar M Lourenço
Journal:  Front Endocrinol (Lausanne)       Date:  2018-07-17       Impact factor: 5.555

7.  Total and Subtotal Parathyroidectomy in Young Patients With Multiple Endocrine Neoplasia Type 1-Related Primary Hyperparathyroidism: Potential Post-surgical Benefits and Complications.

Authors:  Francesco Tonelli; Francesca Marini; Francesca Giusti; Maria Luisa Brandi
Journal:  Front Endocrinol (Lausanne)       Date:  2018-09-24       Impact factor: 5.555

Review 8.  Multiple Endocrine Neoplasia Type 1: Latest Insights.

Authors:  Maria Luisa Brandi; Sunita K Agarwal; Nancy D Perrier; Kate E Lines; Gerlof D Valk; Rajesh V Thakker
Journal:  Endocr Rev       Date:  2021-03-15       Impact factor: 19.871

9.  Intraoperative Decision-Making and Technical Aspects of Parathyroidectomy in Young Patients With MEN1 Related Hyperparathyroidism.

Authors:  Priscilla F Nobecourt; Jonathan Zagzag; Elliot A Asare; Nancy D Perrier
Journal:  Front Endocrinol (Lausanne)       Date:  2018-10-16       Impact factor: 5.555

10.  When Parathyroidectomy Should Be Indicated or Postponed in Adolescents With MEN1-Related Primary Hyperparathyroidism.

Authors:  Francesca Marini; Francesca Giusti; Francesco Tonelli; Maria Luisa Brandi
Journal:  Front Endocrinol (Lausanne)       Date:  2018-10-05       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.